- Home
- Labeler Index
- Ascendis Pharma, Endocrinology, Inc.
- 73362-100
- NDC Crossover: 73362-100 Yorvipath
NDC Crossover 73362-100 Yorvipath
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Palopegteriparatide
The Similar Products in this help users find alternative medications and related products based on key similarities in their regulatory status, product name, active ingredients, dosage form, and administration route.
Explore similar products to 73362-100 – Yorvipath, a human prescription drug. This list includes other cross-matching products that share:
- The same product name: Yorvipath
- OR Generic name: Palopegteriparatide
- AND the same Administration Route: subcutaneous
- OR Dosage Form: injection, solution
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 73362-101 | Yorvipath | Palopegteriparatide | Injection, Solution | Subcutaneous | Ascendis Pharma, Endocrinology, Inc. | Human Prescription Drug |
| 73362-102 | Yorvipath | Palopegteriparatide | Injection, Solution | Subcutaneous | Ascendis Pharma, Endocrinology, Inc. | Human Prescription Drug |
